Our Mission

MyCARE’s mission is to provide a voice to mycology patients in order to increase awareness, educate and support patients and caregivers, share resources, and ultimately improve outcomes in mycology. We support patients and caregivers impacted by serious, chronic, or invasive fungal infections through advocacy, research, and education.

Support MyCARE!

Mycology Advocacy, Research & Education (MYCARE) Foundation is dedicated to improving outcomes for patients with serious or invasive fungal infections. As we build our network, we will provide multiple opportunities to support our mission financially. For now, if you would like to contribute to MyCARE, please click the donate button.

SHARE YOUR STORY

CAN YOU RELATE?

Sharing your experience with Cocci can be a powerful experience. Thinking through your own experience–whether as a patient or a caregiver—can give you perspective and help you appreciate all of the hard work you have done battling Cocci. Your story can also provide hope to those at different stages in their own journey. Please consider click on the fungal infection below to share your experience in that area:

Comprehensive Content on Key Fungal Infections.

Learn about the disease, risk factors, diagnosis, treatment, and so much more!

Cocci (Valley Fever)

Aspergillosis 

Invasive Candidiasis

Non-Aspergillus Molds

Help Doctors Understand the Patient Experience with Fungal Infections

The Mycoses Study Group is conducting a study to better understand what it’s like to live with and be treated for a serious fungal infection—specifically histoplasmosisblastomycosis, or coccidioidomycosis (Valley Fever).
We need your voice.
Your participation will directly inform doctors and researchers about how these infections—and the treatments used to manage them—impact patients’ lives. This information is critical to improving care, ensuring treatments are more effective, and making the healthcare system more responsive to patients’ needs.
By sharing your experience, you’ll be helping doctors better understand antifungal medications and the challenges patients face—something they can only learn from you.
Join the study today and help shape the future of fungal infection treatment.
Learn More

MyCARE has been getting the word out!

MyCARE has been raising awareness of the importance of patient advocacy and building our network at:

  • ASM Microbe, June 19-23, 2025
  • Cocci Study Group, April 4-5, 2025, Phoenix, Arizona
  • GlobalSkin Conference, April 24-27, 2025, Prague, Czech Republic
  • UN General Assembly High-Level Meeting on Antimicrobial Resistance 2024, September 26, 2024, New York NY
  • ID Week, October 16-20, 2024, Los Angeles, California
  • PCORI Annual Meeting, October 22-23, 2024, Washington, DC
  • Pan American World Health Organization G20 Meeting on Antimicrobial Resistance, September 1-3, 2024, Natal, Brazil
  • World AMR Congress & Disease Prevention Control Summit, Washington DC, September 4-6, 2024
  • MSGERC Biennial Meeting, September 4-6, 2024, Colorado Springs, Colorado
  • ESCMID Global, April 27-30, 2024 Barcelona, Spain

MyCARE will be at the following meetings:

  • TIMM, Sep. 19-22, 2025 Bilbao Spain
  • ID Week, Oct. 19-22, 2025, Atlanta, Georgia
  • Cocci Study Group 8th Annual International Meeting, August 20-23, 2026 Sacramento, California
  • MSGERC Biennial Meeting, September 9-11, 2026, Broomfield, ColoradoIf you know of other meetings we should be attending please let us know.

Our Story

Fungal infections have received a lot of attention lately. For those impacted by these diseases and those caring for them as caregivers or clinicians, the attention is long overdue. In 2022, the World Health Organization released a priority list of fungal infections, identifying the fungal diseases of most concern. Hollywood also brought attention to fungal diseases through the series The Last of Us, and increased the amount of media attention surrounding these diseases. Often, the challenges of diagnosing and treating severe, chronic or invasive fungal infections (IFIs) is exacerbated by a lack of vetted information, guidance, institutional access, resources, and peer support for patients and their caregivers. Many patients and caregivers suffer in silence, not knowing where to turn when they hit informational, financial, or resource road blocks.

Patients with invasive or severe fungal infections need advocacy, but a pan-fungal advocacy effort has not been available–until now. Drawing upon the seminal patient-directed work of groups such as the Valley Fever Institute and the Mycoses Study Group Education & Research Foundation (MSGERC), we have launched Mycology Advocacy, Research & Education, MyCARE. MyCARE is the first pan-fungal patient advocacy effort. Learn more about our mission and our inaugural event, the Pan-Fungal Patient/Stakeholder IFI summit, held May 19-May 20th, 2023.

The mission of MYCARE includes education, including supporting stakeholders and elected representatives in their educational efforts.

Representative Michael Burgess, MD (TX-26) used his time at the House Energy & Commerce Hearing on “Antimicrobial Resistance: Examining an Emerging Public Health Threat” held on April 28, 2023 to educate the committee on the growing impact of Valley Fever and other fungal infections. MYCARE Founding Member Rob Purdie’s efforts are specifically mentioned in the response from Kevin Outterson, ESQ, Executive Director of CARB-X.

MyCARE is a valued educational resource for stakeholders, elected officials, media, the public, and most importantly, patients and caregivers.  To continue our mission, we need your help.  Please consider sharing your experience as well as what resources would be beneficial to you.

powered by Advanced iFrame